-+ 0.00%
-+ 0.00%
-+ 0.00%

Lyell Immunopharma Launches Phase 3 Head-to-Head CAR T-Cell Therapy Trial in Large B-Cell Lymphoma

Reuters·11/12/2025 21:05:39

Please log in to view news